| 1例冠状动脉支架植入术后患者行髋关节翻修术的围术期抗栓治疗并文献复习 |
| |
| 引用本文： | 李莹,曹爱霖,鲍蕾蕾,王占坤,钱皎. 1例冠状动脉支架植入术后患者行髋关节翻修术的围术期抗栓治疗并文献复习[J]. 药学实践杂志, 2022, 40(4): 372-373,386 |
| |
| 作者姓名： | 李莹 曹爱霖 鲍蕾蕾 王占坤 钱皎 |
| |
| 作者单位： | 海军军医大学第一附属医院药学部, 上海 200433;上海市皮肤病医院，同济大学附属皮肤病医院药剂科，上海 200443;保定市第二中心医院药剂科, 河北 保定 072750 |
| |
| 基金项目： | 2019年上海市“医苑新星”青年医学人才培养资助计划；上海市科学技术委员会科研计划项目（18401933000） |
| |
| 摘 要： | 目的 探讨冠状动脉支架植入术后患者行髋关节翻修术围术期抗栓治疗策略。方法 对1例冠状动脉支架植入术后患者行髋关节翻修术的抗栓治疗进行分析，并进行相关文献复习。结果 患者术后出现急性非ST段抬高性心肌梗死，系因术前3 d即停用阿司匹林，期间亦未用低分子肝素桥接抗凝所致，并对术后急性冠状动脉综合征抗栓及静脉血栓栓塞症预防方案进行分析。结论 冠状动脉支架植入术后行髋关节翻修术患者围术期应平衡血栓形成与出血风险，合理选择抗栓治疗方案。
|
| 关 键 词： | 冠状动脉支架植入术 髋关节翻修术 围术期 抗栓治疗 |
| 收稿时间： | 2021-03-25 |
| 修稿时间： | 2021-06-09 |
Perioperative antithrombotic therapy in the patient undergoing revision total hip arthroplasty after coronary stent implantation: a case report and literature review |
| |
| LI Ying,CAO Ailin,BAO Leilei,WANG Zhankun,QIAN Jiao. Perioperative antithrombotic therapy in the patient undergoing revision total hip arthroplasty after coronary stent implantation: a case report and literature review[J]. The Journal of Pharmaceutical Practice, 2022, 40(4): 372-373,386 |
| |
| Authors: | LI Ying CAO Ailin BAO Leilei WANG Zhankun QIAN Jiao |
| |
| Affiliation: | Department of Pharmacy, the First Affiliated Hospital of Naval Medical University, Shanghai 200433, China;Department of Pharmacy, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200443, China;Department of Pharmacy, Baoding Second Central Hospital, Baoding 072750, China |
| |
| Abstract: | Objective To explore the strategies of perioperative antithrombotic therapy in the patient undergoing revision total hip arthroplasty after coronary stent implantation. Methods The antithrombotic therapy in one patient undergoing revision total hip arthroplasty after coronary stent implantation was analyzed with the review of related literatures. Results The patient developed non-ST segment elevated myocardial infarction due to the stop of aspirin three days before operation and no low molecular weight heparin was used. The antithrombotic treatment and prevention of venous thromboembolism were analyzed. Conclusion Antithrombotic therapy should be selected reasonably in patients undergoing revision total hip arthroplasty after coronary stent implantation. |
| |
| Keywords: | coronary stent implantation revision total hip arthroplasty perioperative period antithrombotic therapy |
|
| 点击此处可从《药学实践杂志》浏览原始摘要信息 |
|
点击此处可从《药学实践杂志》下载全文 |
